UroGen settles JELMYTO patent litigation with Teva
Go back to UroGen settles JELMYTO patent litigation with Teva| (NASDAQ: URGN) | Delayed: 34.56 -2.05 (5.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.61 | 52 Week High | $ | |||
| Open | $36.35 | 52 Week Low | $ | |||
| Day High | $36.91 | P/E | N/A | |||
| Day Low | $34.26 | EPS | $ | |||
| Volume | 1,057,198 | |||||



